Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
211.93+0.55 (+0.26%)
At close: 04:00PM EDT
211.93 0.00 (0.00%)
After hours: 07:53PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close211.38
Open211.38
Bid207.11 x 800
Ask215.00 x 800
Day's Range207.19 - 212.71
52 Week Range187.16 - 372.12
Volume2,947,056
Avg. Volume1,106,185
Market Cap31.131B
Beta (5Y Monthly)0.44
PE Ratio (TTM)20.74
EPS (TTM)10.22
Earnings DateApr 20, 2022 - Apr 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est242.00
  • MarketWatch

    Biogen stops clinical trial tracking Aduhelm

    Biogen Inc. said in a statement that it stopped a post-marketing clinical trial testing its Alzheimer's disease therapy Aduhelm, citing a Medicare policy that will limit usage of the drug. The company updated the study's ClinicalTrials.gov

  • American City Business Journals

    Executive Voice: Seasoned leader steers North Carolina toward growth

    Machelle Sanders, secretary of the Department of Commerce for North Carolina, climbed the corporate ranks before taking charge of the state's thriving economic development prospects. Now, she must keep the momentum going.

  • News Direct

    Biogen Celebrates 20 Years of Caring Deeply

    Armany is a rising junior at Northeastern University majoring in electrical and computer engineering who developed a passion for science during his time as a Biogen Community Lab student and as a R...

Advertisement
Advertisement